Matthew J. Wyvratt - Concepedia

Author

Matthew J. Wyvratt

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

M J Wyvratt, M Wyvratt, M. J. JUN. WYVRATT, M. J. WYVRATT, M. J. Wyvratt, M. WYVRATT, M.J. Wyvratt, MATTHEW J. WYVRATT, Matthew J Wyvratt, Matthew J. Wyvratt

174

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Matthew J. Wyvratt is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	89	4.6K
2	Engineering	12	13	417
3	Health Sciences	3	3	135
4	Arts	1	1	14
5	Education	1	1	84

Matthew J. Wyvratt

114

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes Dooseop Kim, Liping Wang, Maria Beconi, Journal of Medicinal Chemistry	2004	808
A new class of angiotensin-converting enzyme inhibitors Arthur A. Patchett, Elbert E. Harris, Edward W. Tristram, Nature Medicinal ChemistryMedicineAntihypertensive TherapyCardiovascular PharmacologyNew Class	1980	706
A Nonpeptidyl Growth Hormone Secretagogue Roy G. Smith, Kang Cheng, William R. Schoen, Science Signal TransductionPituitary GlandBiochemistryHuman GrowthMedicine	1993	348
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. Francis J. Dumont, Mary Jo Staruch, Sam L. Koprak, The Journal of Experimental Medicine ImmunotoxicologyToxic EffectsImmunologyCell DeathPharmacotherapy	1992	253
Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides Linda Brockunier, Emma R. Parmee, Hyun Ok, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinePharmacological AgentExperimental PharmacologyPharmacotherapy	2000	199
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum Akhil B. Vaidya, Joanne M. Morrisey, Zhongsheng Zhang, Nature Communications	2014	131
Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Smith Rg, Pong Ss, Gerard J. Hickey, PubMed Human GrowthPulsatile Gh ReleasePituitary GlandNeuroendocrine MechanismPituitary Disease	1996	119
A Novel 3-Substituted Benzazepinone Growth Hormone Secretagogue (L-692,429) William R. Schoen, Judith M. Pisano, Matthew J. Wyvratt, Journal of Medicinal Chemistry Medicinal ChemistryGrowth HormoneBiochemistry3-Substituted BenzazepinoneMedicine	1994	101
Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents Tesfaye Biftu, Dennis Feng, Michael H. Fisher, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNatural SciencesAntibacterial AgentAntimicrobial Compound	2006	97
Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles Thomas M. Jacks, Gerard J. Hickey, F.R. JUDITH, Journal of Endocrinology Animal PhysiologyVeterinary PhysiologyGrowth HormoneIntravenous AdministrationEndocrine Mechanism	1994	84

Page 1